Concise review: no breakthroughs for human mesenchymal and embryonic stem cell culture: conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum, or enriched plasma; serum-free, serum replacement nonconditioned med
about
Using mesenchymal stem cells as a therapy for bone regeneration and repairingStem Cells of Dental Origin: Current Research Trends and Key Milestones towards Clinical ApplicationFrom pluripotency to myogenesis: a multistep process in the dishMaking the Switch: Alternatives to Fetal Bovine Serum for Adipose-Derived Stromal Cell ExpansionA xenogeneic-free protocol for isolation and expansion of human adipose stem cells for clinical usesAutomated image analysis with the potential for process quality control applications in stem cell maintenance and differentiationFeasibility and Efficiency of Human Bone Marrow Stromal Cell Culture with Allogeneic Platelet Lysate-Supplementation for Cell Therapy against StrokeIntravenous transplantation of mesenchymal stem cells preconditioned with early phase stroke serum: current evidence and study protocol for a randomized trial.Current status of cell therapies in stroke.Safety and Feasibility of Autologous Mesenchymal Stem Cell Transplantation in Chronic Stroke in Indian patients. A four-year follow upTreatment of erectile dysfunction in the obese type 2 diabetic ZDF rat with adipose tissue-derived stem cellsConcise review: mind the gap: challenges in characterizing and quantifying cell- and tissue-based therapies for clinical translation.Manufacturing and banking of mesenchymal stem cells.Human bone marrow mesenchymal progenitors: perspectives on an optimized in vitro manipulation.Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices.Electric pulses to prepare feeder cells for sustaining and culturing of undifferentiated embryonic stem cells.Human serum promotes osteogenic differentiation of human dental pulp stem cells in vitro and in vivo.Functional and differential proteomic analyses to identify platelet derived factors affecting ex vivo expansion of mesenchymal stromal cellsTranslating research into clinical scale manufacturing of mesenchymal stromal cells.Musculoskeletal tissue engineering with human umbilical cord mesenchymal stromal cells.Assessment of an efficient xeno-free culture system of human periodontal ligament stem cells.Serum-free and xenobiotic-free preservation of cultured human limbal epithelial cells.Macromolecularly crowded in vitro microenvironments accelerate the production of extracellular matrix-rich supramolecular assemblies.Human adipose tissue-derived stem cells cultured in xeno-free culture condition enhance c-MYC expression increasing proliferation but bypassing spontaneous cell transformation.Point-of-care seeding of nitinol stents with blood-derived endothelial cells.Optimization of Buffalo (Bubalus bubalis) Embryonic Stem Cell Culture System.Manufacturing of dental pulp cell-based products from human third molars: current strategies and future investigations.Development of a Xeno-Free Feeder-Layer System from Human Umbilical Cord Mesenchymal Stem Cells for Prolonged Expansion of Human Induced Pluripotent Stem Cells in CultureEstablishment of a xeno-free culture system that preserves the characteristics of placenta mesenchymal stem cells.Human umbilical cord blood plasma can replace fetal bovine serum for in vitro expansion of functional human endothelial colony-forming cells.Derivation of a novel undifferentiated human foetal phenotype in serum-free cultures with BMP-2.Establishing a stem cell culture laboratory for clinical trials.Retinal pigment epithelium culture;a potential source of retinal stem cellsAlginate-Encapsulation for the Improved Hypothermic Preservation of Human Adipose-Derived Stem Cells.Advancing biomaterials of human origin for tissue engineering.Characterization of human skin-derived mesenchymal stem cell proliferation rate in different growth conditions.Adult mesenchymal stromal stem cells for therapeutic applications.Influence of culture medium on smooth muscle cell differentiation from human bone marrow-derived mesenchymal stem cells.Age-old wisdom concerning cell-based therapies with added knowledge in the stem cell era: our perspectives.Enumeration of the colony-forming units-fibroblast from mouse and human bone marrow in normal and pathological conditions.
P2860
Q26777025-6B838595-85E8-4BAC-B1B3-EA6660A24185Q28073659-DCE5F189-200B-4E7A-B306-07AB5E58AE7BQ28076485-B91F08B8-FC66-4A25-896F-417F27C463ADQ28079988-B019ADBF-AB86-4F39-AC01-EBF8E344F6C4Q28534582-A5A1DD8F-77BA-4E57-84A3-C2E1C7D572F0Q28829627-E892BE81-5890-4D26-B486-3E2DD2F6903BQ30370083-09A18BBF-18C0-4258-9300-93BCF28AB861Q33592708-D6364897-05D9-4142-B177-750F1A21D9FCQ33614825-28C74DDB-8862-4354-BA0C-D7A833D069E7Q33863334-A0099713-1C71-4F74-881E-8243497ECC6EQ33994488-5EE3E281-6592-4DA6-9DE9-B07CA6D949E3Q34234490-387FC5F8-BEF1-4018-824C-C7AE9C973947Q34323739-425BDE4E-F1AC-4A2E-8D67-FE48F214B2B9Q34391255-CFF07C06-69A5-42A9-8346-54DAAB256A01Q34422955-7AE817C9-1D1D-4957-9C6C-E01CF5CAFB3BQ34458742-8F45F59F-EE65-44E2-8697-9D9E002E9C22Q34500457-0E295B75-29B5-4CCB-AFC5-8B4AFB0AEFABQ34507997-EF8528D1-7090-4FFC-8E46-3CD5468B47DAQ34557484-F0574F2C-F742-4B39-855E-F58C12653B6BQ34673909-C97EA8DF-763C-4594-B7FC-3A4674BBC44BQ34915107-A4400CDC-E5D1-4C09-810A-1B26A14249D9Q35143610-6465D14D-76F8-4E10-87FC-1EFE152F0E54Q35144214-728CC42A-BDCE-4B0A-BD53-2A730A486DA3Q35683429-4BFCA508-384B-4649-A4B8-D2AC723DF30DQ35764630-3F46749D-D238-49DD-96DF-19ECF9FB1DCAQ35856024-B1491F8F-9DFA-40F1-8044-98DC7F68752EQ35921981-D09B6072-F40E-47E1-92B8-94F6EB9FF502Q35925098-0A6B9213-C776-44FF-8DF2-4BB51FAB2071Q35984420-2D5256F2-B387-4790-BF17-EF8EAB18F94CQ36071299-7667E528-0354-420B-95BD-F74CD3189D03Q36199189-B39730A3-220B-4A8C-AA5B-186560BDD508Q36283870-D0F9F2B3-4194-403B-8A0B-77F21D5B30E1Q36400169-6FA8D2EA-038C-4AE6-ADDC-76120B170778Q36728541-13398994-8578-40D8-BA5C-FB106CBB0A35Q36729634-D03A2351-FDD4-4A03-980B-B68CEAD08841Q37120340-CC53942B-EBEF-45DE-BC28-90154207ED93Q37157668-D78CFCAD-F8C3-48B8-BBE7-E19F13DBDF4BQ37276870-F3F2C644-EF10-49EC-A509-AC6A6F491952Q37362810-8DCFB64E-2BCE-4124-8EDF-6B2B0A76E475Q37367098-529C7E33-316F-438A-B4EA-186772C4A592
P2860
Concise review: no breakthroughs for human mesenchymal and embryonic stem cell culture: conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum, or enriched plasma; serum-free, serum replacement nonconditioned med
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Concise review: no breakthroug ...... replacement nonconditioned med
@ast
Concise review: no breakthroug ...... replacement nonconditioned med
@en
type
label
Concise review: no breakthroug ...... replacement nonconditioned med
@ast
Concise review: no breakthroug ...... replacement nonconditioned med
@en
prefLabel
Concise review: no breakthroug ...... replacement nonconditioned med
@ast
Concise review: no breakthroug ...... replacement nonconditioned med
@en
P1433
P1476
Concise review: no breakthroug ...... replacement nonconditioned med
@en
P2093
Ferdinando Mannello
Gaetana A Tonti
P304
P356
10.1634/STEMCELLS.2007-0127
P577
2007-03-29T00:00:00Z